Exane Asset Management »

Apogee Therapeutics shares owned by Exane Asset Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Exane Asset Management from 13F filings

Historical chart of Exane Asset Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Exane Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Exane Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $593k 10k 58.74

More positions owned by Exane Asset Management

Ubs Group Stock (UBS)
Bank America Corp Stock (BAC)
Coca-cola Europacific Partne Stock (CCEP)
Stellantis Stock (STLA)
T-mobile Us Stock (TMUS)
Crh Plc Ord Stock (CRH)
Qiagen Nv Stock (QGEN)
Amazon Stock (AMZN)
INTERNATIONAL FLAVORS and FRAGRA Stock (IFF)
Alcon Ag Ord Stock (ALC)
Oracle Corp Stock (ORCL)
Procore Technologies Stock (PCOR)
Elastic N V Ord Stock (ESTC)
Crowdstrike Hldgs Inc Cl A Stock (CRWD)
Biogen Stock (BIIB)

View all positions for Exane Asset Management

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
BlackRock
Driehaus Capital Management
Fairmount Funds Management
Perceptive Advisors
Vanguard Group
RA Capital Management
Braidwell
State Street Corporation
Alliancebernstein
Deep Track Capital
Woodline Partners
Franklin Resources
Geode Capital Management

View all funds holding Apogee Therapeutics